DANAHER Share Price Other OTC
Stocks
US2358513008
Advanced Medical Equipment & Technology
| Market Cap | 137B 119B 111B 102B 193B 13,025B 195B 1,307B 511B 6,511B 514B 503B 21,574B | P/E 2026 * |
32.6x | P/E 2027 * | 26.8x |
|---|---|---|---|---|---|
| Enterprise Value | 157B 136B 127B 117B 221B 14,933B 223B 1,498B 586B 7,465B 590B 577B 24,735B | EV / Sales 2026 * |
5.96x | EV / Sales 2027 * | 5.32x |
| Free-Float |
70.58% | Yield 2026 * |
0.75% | Yield 2027 * | 0.8% |
Last Transcript: DANAHER
| 1 day | +0.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 62 | 31/08/2020 |
Matthew Gugino
DFI | Director of Finance/CFO | - | 27/02/2026 |
Steven Dee
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Alan Spoon
BRD | Director/Board Member | 74 | 30/06/1999 |
Steven Rales
CHM | Chairman | 74 | 31/12/1983 |
Mitchell Rales
BRD | Director/Board Member | 69 | 31/12/1983 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.07% | -1.98% | - | - | 137B | |
| -1.62% | -2.02% | +21.04% | +2.94% | 209B | |
| -1.90% | +1.79% | -23.81% | +19.06% | 130B | |
| +1.36% | +6.58% | -54.03% | -3.21% | 71.14B | |
| +0.88% | +7.07% | +11.87% | +12.63% | 51.59B | |
| +0.24% | +3.89% | -14.79% | -20.07% | 49.99B | |
| -0.43% | -0.95% | +21.21% | +10.21% | 39.31B | |
| +5.69% | +3.17% | +38.69% | +36.63% | 38.89B | |
| +0.76% | +9.59% | -0.54% | -7.43% | 31.74B | |
| +3.69% | +6.79% | -23.44% | +24.49% | 32.19B | |
| Average | +1.19% | +4.50% | -2.64% | +8.36% | 72.64B | |
| Weighted average by Cap. | +0.87% | +2.56% | -1.69% | +7.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.34B 22.87B 21.33B 19.59B 37.05B 2,506B 37.46B 251B 98.29B 1,253B 98.93B 96.76B 4,150B | 28.46B 24.72B 23.04B 21.17B 40.04B 2,708B 40.48B 272B 106B 1,353B 107B 105B 4,485B |
| Net income | 4.24B 3.68B 3.43B 3.15B 5.97B 403B 6.03B 40.48B 15.82B 202B 15.93B 15.58B 668B | 5.19B 4.5B 4.2B 3.86B 7.29B 493B 7.37B 49.49B 19.35B 247B 19.47B 19.05B 817B |
| Net Debt | 20.06B 17.42B 16.24B 14.92B 28.22B 1,908B 28.53B 191B 74.86B 954B 75.34B 73.69B 3,161B | 14.54B 12.63B 11.77B 10.81B 20.45B 1,383B 20.68B 139B 54.25B 691B 54.6B 53.41B 2,291B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
